Related Experiment Video
Updated: Jul 19, 2026
15:24
Testing Cancer Immunotherapeutics in a Humanized Mouse Model Bearing Human Tumors
Published on: December 16, 2022
Human gamma delta T cells and tumor immunotherapy
1Laboratory of Immunology and Cell Biology, Graduate School of Biostudies, Kyoto University, Kyoto, Japan.
Journal of Clinical and Experimental Hematopathology : JCEH
|October 25, 2006
Summary
Human gamma delta T cells are crucial for fighting infections and cancer. Research reveals their TCR-dependent recognition of microbial and tumor antigens, paving the way for novel immunotherapies.
Area of Science:
- Immunology
- Cellular Biology
- Microbiology
Background:
- Human Vgamma2Vdelta2 T cells recognize nonpeptide antigens from microbes like mycobacteria and malaria parasites via T-cell receptor (TCR)-dependent mechanisms.
- These T cells are implicated in infectious immunity, with their precise recognition mechanisms elucidated through structural studies.
- Evidence also suggests a role for human gamma delta T cells in tumor immunity, exhibiting cytolytic activity against various cancer cells.
Purpose of the Study:
- To investigate the dual role of human gamma delta T cells in both infectious and tumor immunity.
- To explore the TCR-dependent and natural killer-like pathways utilized by gamma delta T cells in anti-tumor responses.
- To assess the potential of nitrogen-containing bisphosphonates in generating tumor-specific antigens for gamma delta T cell recognition.
Main Methods:
- Site-directed mutagenesis based on crystal structure of gamma delta TCR to delineate recognition mechanisms.
- Analysis of gamma delta T cell cytolytic activity against diverse tumor cell lines.
- Treatment of human tumor cells with nitrogen-containing bisphosphonates to assess antigen generation and subsequent TCR-dependent recognition by gamma delta T cells.
Main Results:
- Human Vgamma2Vdelta2 T cells recognize microbial antigens in a TCR-dependent manner, confirming their role in infectious immunity.
- Human gamma delta T cells employ distinct pathways for anti-tumor immunity: a natural killer-like pathway and a TCR-dependent pathway.
- Nitrogen-containing bisphosphonates can modify tumor cells to display antigens recognized by gamma delta T cells in a TCR-dependent manner.
Conclusions:
- Human gamma delta T cells are versatile immune cells involved in recognizing both microbial and tumor-associated antigens.
- The distinct recognition pathways highlight the adaptability of gamma delta T cells in immune surveillance.
- Bisphosphonate-induced tumor cell labeling offers a promising strategy for developing novel TCR-dependent cancer immunotherapies.
